Welcome to our dedicated page for Tharimmune news (Ticker: THAR), a resource for investors and traders seeking the latest updates and insights on Tharimmune stock.
Tharimmune Inc. changed its corporate name to Canton Strategic Holdings, Inc. and its Nasdaq ticker from THAR to CNTN as part of a shift toward a Canton Network digital asset treasury strategy. News about the company centers on Canton Coin acquisition, Super Validator operations, participation in Canton Foundation governance, applications supporting institutional use of the Canton Network, equity financing, and board and executive appointments.
The company also reports clinical-stage biotechnology research and development activity, making its updates a mix of digital asset treasury execution, blockchain market-infrastructure commentary, capital-structure actions, governance changes, and biotech R&D disclosures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.